Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1056

1.

Management of postmenopausal osteoporosis and the prevention of fractures.

Gambacciani M, Levancini M.

Panminerva Med. 2014 Jun;56(2):115-31. Epub 2014 Jun 19.

2.

How to manage postmenopausal osteoporosis?

Body JJ.

Acta Clin Belg. 2011 Nov-Dec;66(6):443-7. Review.

PMID:
22338309
3.

Hormone replacement therapy and the prevention of postmenopausal osteoporosis.

Gambacciani M, Levancini M.

Prz Menopauzalny. 2014 Sep;13(4):213-20. doi: 10.5114/pm.2014.44996. Epub 2014 Sep 9.

4.
5.

Individualizing osteoporosis therapy.

Silverman S, Christiansen C.

Osteoporos Int. 2012 Mar;23(3):797-809. doi: 10.1007/s00198-011-1775-y. Epub 2012 Jan 5. Review.

PMID:
22218417
6.

New developments in the treatment of osteoporosis.

Eriksen EF, Halse J, Moen MH.

Acta Obstet Gynecol Scand. 2013 Jun;92(6):620-36. doi: 10.1111/j.1600-0412.2012.01473.x. Review.

PMID:
22646526
7.

Treatment of post-menopausal osteoporosis: beyond bisphosphonates.

Ishtiaq S, Fogelman I, Hampson G.

J Endocrinol Invest. 2015 Jan;38(1):13-29. doi: 10.1007/s40618-014-0152-z. Epub 2014 Sep 7. Review.

PMID:
25194424
8.
9.

Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.

Reginster JY.

Drugs. 2011 Jan 1;71(1):65-78. doi: 10.2165/11587570-000000000-00000. Review.

10.

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.

Wensel TM, Iranikhah MM, Wilborn TW.

Pharmacotherapy. 2011 May;31(5):510-23. doi: 10.1592/phco.31.5.510. Review.

PMID:
21923432
11.
12.

Prevention and treatment of postmenopausal osteoporosis.

Tella SH, Gallagher JC.

J Steroid Biochem Mol Biol. 2014 Jul;142:155-70. doi: 10.1016/j.jsbmb.2013.09.008. Epub 2013 Oct 29. Review.

13.

Developments in the pharmacotherapeutic management of osteoporosis.

Close P, Neuprez A, Reginster JY.

Expert Opin Pharmacother. 2006 Aug;7(12):1603-15. Review.

PMID:
16872263
14.

Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.

Lewiecki EM.

J Womens Health (Larchmt). 2009 Oct;18(10):1615-26. doi: 10.1089/jwh.2008.1086. Review.

PMID:
19857095
15.

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.

Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjærg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD; Bazedoxifene Study Group.

Osteoporos Int. 2012 Jan;23(1):351-63. doi: 10.1007/s00198-011-1691-1. Epub 2011 Jul 21.

PMID:
21779819
16.

Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.

Gallacher SJ, Dixon T.

Calcif Tissue Int. 2010 Dec;87(6):469-84. doi: 10.1007/s00223-010-9420-x. Epub 2010 Sep 26. Review.

PMID:
20872215
17.

What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?

Miller PD, Derman RJ.

Osteoporos Int. 2010 Nov;21(11):1793-802. doi: 10.1007/s00198-010-1208-3. Epub 2010 Mar 23. Review.

PMID:
20309524
18.

Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.

Leder BZ, Tsai JN, Uihlein AV, Burnett-Bowie SA, Zhu Y, Foley K, Lee H, Neer RM.

J Clin Endocrinol Metab. 2014 May;99(5):1694-700. doi: 10.1210/jc.2013-4440. Epub 2014 Feb 11.

19.

New management options for osteoporosis with emphasis on SERMs.

McClung MR.

Climacteric. 2015;18 Suppl 2:56-61. doi: 10.3109/13697137.2015.1104010. Epub 2015 Oct 27. Review.

PMID:
26503459
20.

Selective estrogen modulators in menopause.

Gambacciani M.

Minerva Ginecol. 2013 Dec;65(6):621-30.

PMID:
24346250

Supplemental Content

Support Center